Search results
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
Zacks via Yahoo Finance· 1 day agoShares of this pharmaceutical company have returned +2.2% over the past month versus the Zacks S&P...
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 2 days agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar...
Merck First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 4 days agoNYSE:MRK Earnings and Revenue Growth May 6th 2024 Merck Revenues and Earnings Beat Expectations...
...ETFs Post Q1 Earnings - Bristol-Myers Squibb (NYSE:BMY), First Trust Nasdaq Pharmaceuticals ETF...
Benzinga· 1 day agoThe first-quarter results of the healthcare sector have been unimpressive, with earnings of 78% of...
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Call Transcript May 7, 2024...
Ligand (LGND) Beats Q1 Earnings, Misses Sales Estimates
Zacks via Yahoo Finance· 2 days agoThe upside was driven by increased royalties from Amgen’s Kyprolis, Jazz Pharmaceuticals’ Rylaze, ...
OPKO Health's (OPK) Q1 Earnings Miss Estimates, Sales Down Y/Y
Zacks· 1 day agoOPKO Health's (OPK) first-quarter results reflect soft performances despite robust RAYALDEE sales and strength in the Pharmaceuticals segment.
Drugmakers in Medicare Price Talks Spent Less on R&D Than on Shareholders, Marketing, Overhead:...
The Fiscal Times via Yahoo Finance· 18 hours agoThe report says that the eight companies — Johnson & Johnson, Amgen, AstraZeneca, Bristol Myers...
Hearing set to consider penalties for pharmaceutical company over Arkansas law | Northwest Arkansas...
Northwest Arkansas Democrat Gazette· 5 days agoA battle between the Arkansas Insurance Department and pharmaceutical manufacturers is heating up...
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
Zacks· 12 hours agoFree Report) incurred a loss of 42 cents per share in first-quarter 2024, narrower than the Zacks Consensus Estimate of a loss of 45 cents. During the quarter, the company generated total revenues ...
